摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

17-(cyclopropylmethyl)-6,7-dehydro-4,5α-epoxy-3,14-dihydroxy-5',7'-dibromo-6,7-2',3'-(1'-ethyl)-indolomorphinan | 188258-73-3

中文名称
——
中文别名
——
英文名称
17-(cyclopropylmethyl)-6,7-dehydro-4,5α-epoxy-3,14-dihydroxy-5',7'-dibromo-6,7-2',3'-(1'-ethyl)-indolomorphinan
英文别名
(1S,2S,13R,21R)-7,9-dibromo-22-(cyclopropylmethyl)-11-ethyl-14-oxa-11,22-diazaheptacyclo[13.9.1.01,13.02,21.04,12.05,10.019,25]pentacosa-4(12),5(10),6,8,15,17,19(25)-heptaene-2,16-diol
17-(cyclopropylmethyl)-6,7-dehydro-4,5α-epoxy-3,14-dihydroxy-5',7'-dibromo-6,7-2',3'-(1'-ethyl)-indolomorphinan化学式
CAS
188258-73-3
化学式
C28H28Br2N2O3
mdl
——
分子量
600.35
InChiKey
NHRJLLKBHSLUHM-OZBXUNDUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.9
  • 重原子数:
    35
  • 可旋转键数:
    3
  • 环数:
    8.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    57.9
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    17-(cyclopropylmethyl)-6,7-dehydro-4,5α-epoxy-3,14-dihydroxy-5',7'-dibromo-6,7-2',3'-(1'-ethyl)-indolomorphinan 在 palladium on activated charcoal 氢气三乙胺 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 2.0h, 以95%的产率得到17-(cyclopropylmethyl)-6,7-dehydro-4,5α-epoxy-3,14-dihydroxy-6,7-2',3'-(1'-ethyl)-indolomorphinan
    参考文献:
    名称:
    Synthesis of tritiated N1′-alkyl derivatives of the delta opioid receptor ligand naltrindole
    摘要:
    Tritiated N1'-methyI and N1'-ethyl analogues of naltrindole (NTI) have been synthesized for evaluation as radioligands for studies of delta opioid receptors. The two N1'-alkyl-5',7'-dibromoNTI precursors for radiolabeling were prepared by base-promoted alkylation of 2,4-dibromophenylhydrazine with either iodomethane or iodoethane followed by condensation with naltrexone using the Fischer indole synthesis. Catalytic debromotritiation followed by HPLC purification afforded [H-3]MeNTI (17.3 Ci/mmol) and [H-3]EtNTI (22.5 Ci/mmol)with high chemical and radiochemical purities (greater than or equal to 99.8%).
    DOI:
    10.1002/(sici)1099-1344(199702)39:2<115::aid-jlcr947>3.0.co;2-3
  • 作为产物:
    描述:
    盐酸纳曲酮 、 N-ethyl-2,4-dibromophenylhydrazine hydrochloride 在 盐酸溶剂黄146 作用下, 反应 1.0h, 以13%的产率得到17-(cyclopropylmethyl)-6,7-dehydro-4,5α-epoxy-3,14-dihydroxy-5',7'-dibromo-6,7-2',3'-(1'-ethyl)-indolomorphinan
    参考文献:
    名称:
    Synthesis of tritiated N1′-alkyl derivatives of the delta opioid receptor ligand naltrindole
    摘要:
    Tritiated N1'-methyI and N1'-ethyl analogues of naltrindole (NTI) have been synthesized for evaluation as radioligands for studies of delta opioid receptors. The two N1'-alkyl-5',7'-dibromoNTI precursors for radiolabeling were prepared by base-promoted alkylation of 2,4-dibromophenylhydrazine with either iodomethane or iodoethane followed by condensation with naltrexone using the Fischer indole synthesis. Catalytic debromotritiation followed by HPLC purification afforded [H-3]MeNTI (17.3 Ci/mmol) and [H-3]EtNTI (22.5 Ci/mmol)with high chemical and radiochemical purities (greater than or equal to 99.8%).
    DOI:
    10.1002/(sici)1099-1344(199702)39:2<115::aid-jlcr947>3.0.co;2-3
点击查看最新优质反应信息

文献信息

  • Synthesis of tritiated N1′-alkyl derivatives of the delta opioid receptor ligand naltrindole
    作者:John R. Lever、Suzanne M. Johnson
    DOI:10.1002/(sici)1099-1344(199702)39:2<115::aid-jlcr947>3.0.co;2-3
    日期:1997.2
    Tritiated N1'-methyI and N1'-ethyl analogues of naltrindole (NTI) have been synthesized for evaluation as radioligands for studies of delta opioid receptors. The two N1'-alkyl-5',7'-dibromoNTI precursors for radiolabeling were prepared by base-promoted alkylation of 2,4-dibromophenylhydrazine with either iodomethane or iodoethane followed by condensation with naltrexone using the Fischer indole synthesis. Catalytic debromotritiation followed by HPLC purification afforded [H-3]MeNTI (17.3 Ci/mmol) and [H-3]EtNTI (22.5 Ci/mmol)with high chemical and radiochemical purities (greater than or equal to 99.8%).
查看更多